For: | Schinas G, Polyzou E, Dimakopoulou V, Tsoupra S, Gogos C, Akinosoglou K. Immune-mediated liver injury following COVID-19 vaccination. World J Virol 2023; 12(2): 100-108 [PMID: 37033146 DOI: 10.5501/wjv.v12.i2.100] |
---|---|
URL: | https://www.wjgnet.com/2220-3249/full/v12/i2/100.htm |
Number | Citing Articles |
1 |
VV Reshetnikov, GS Shepelkova, AV Rybakova, AP Trashkov, VV Yeremeev, RA Ivanov. The candidate anti-tuberculosis mRNA vaccine immunogenicity and reactogenicity dependency on the animal’s sex and the vaccine dose. Bulletin of Russian State Medical University 2024; (2024(5)) doi: 10.24075/brsmu.2024.045
|
2 |
Meirong Wang, Juan Qi, Yujuan Liu. Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases. Drug Discoveries & Therapeutics 2023; 17(3): 177 doi: 10.5582/ddt.2023.01022
|
3 |
M.E. Zharova, I.O. Ivanikov, Yu.V. Grigorieva, E.L. Nikonov. Liver injury in COVID-19: clinical features and risk factors. Dokazatel'naya gastroenterologiya 2023; 12(3): 51 doi: 10.17116/dokgastro20231203151
|
4 |
Botond Z. Igyártó, Zhen Qin. The mRNA-LNP vaccines – the good, the bad and the ugly?. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336906
|
5 |
Berna İmge Aydoğan, Uğur Ünlütürk, Mustafa Cesur. Diagnosis of latent autoimmune diabetes after SARS–Cov2 vaccination in adult patients previously diagnosed with type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 2024; 44(3): 503 doi: 10.1007/s13410-023-01261-w
|
6 |
Kai Zhu, Olivia Tsai, Daljeet Chahal, Trana Hussaini, Eric M. Yoshida. COVID-19 and Liver Disease: An Evolving Landscape. Seminars in Liver Disease 2023; 43(03): 351 doi: 10.1055/a-2157-3318
|
7 |
Alfonso Rodriguez-Espada, Moises Salgado-de la Mora, Briana Mariette Rodriguez-Paniagua, Nathaly Limon-de la Rosa, Monica Itzel Martinez-Gutierrez, Santiago Pastrana-Brandes, Nalu Navarro-Alvarez. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications. World Journal of Gastroenterology 2024; 30(22): 2866-2880 doi: 10.3748/wjg.v30.i22.2866
|
8 |
Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto, Masanori Abe, Atsumasa Komori, Atsushi Takahashi, Kazuhito Kawata, Ken Sato, Satoru Joshita, Takeji Umemura, Masayuki Ueno, Nobuaki Nakayama, Keisuke Kakisaka, Teruko Arinaga‐Hino, Koichi Ito, Sachiko Kanai, Ryo Miura, Toshihiko Arizumi, Yoshinari Asaoka, Takanori Ito, Tetsuya Shimizu, Hiroshi Yoshida, Masayuki Ohta, Suguru Mizuno, Hiroyuki Isayama, Youichi Morimoto, Satoshi Mochida, Hiromasa Ohira, Atsushi Tanaka. Safety and effectiveness of SARS‐CoV‐2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire‐based, cross‐sectional study. Hepatology Research 2024; 54(7): 706 doi: 10.1111/hepr.14018
|